157 related articles for article (PubMed ID: 20825051)
1. [No association between MTHFR 677C>T polymorphism and ovarian cancer risk in BRCA1 mutation carriers in Wielkopolska region].
Magnowski P; Seremak-Mrozikiewicz A; Nowak-Markwitz E; Kurzawińska G; Drews K; Spaczyński M
Ginekol Pol; 2010 Jul; 81(7):506-10. PubMed ID: 20825051
[TBL] [Abstract][Full Text] [Related]
2. Ovarian cancer risk in Polish BRCA1 mutation carriers is not associated with the prohibitin 3' untranslated region polymorphism.
Jakubowska A; Gronwald J; Menkiszak J; Górski B; Huzarski T; Byrski T; Benner A; Lubiński J; Scott RJ; Hamann U
BMC Cancer; 2008 Apr; 8():90. PubMed ID: 18397521
[TBL] [Abstract][Full Text] [Related]
3. Effect of methylenetetrahydrofolate reductase 677C-->T polymorphism on toxicity and homocysteine plasma level after chronic methotrexate treatment of ovarian cancer patients.
Toffoli G; Russo A; Innocenti F; Corona G; Tumolo S; Sartor F; Mini E; Boiocchi M
Int J Cancer; 2003 Jan; 103(3):294-9. PubMed ID: 12471611
[TBL] [Abstract][Full Text] [Related]
4. Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study.
Jakubowska A; Rozkrut D; Antoniou A; Hamann U; Scott RJ; McGuffog L; Healy S; Sinilnikova OM; Rennert G; Lejbkowicz F; Flugelman A; Andrulis IL; Glendon G; Ozcelik H; ; Thomassen M; Paligo M; Aretini P; ; Kantala J; Aroer B; von Wachenfeldt A; Liljegren A; Loman N; Herbst K; Kristoffersson U; Rosenquist R; Karlsson P; Stenmark-Askmalm M; Melin B; Nathanson KL; Domchek SM; Byrski T; Huzarski T; Gronwald J; Menkiszak J; Cybulski C; Serrano P; Osorio A; Cajal TR; Tsitlaidou M; Benítez J; Gilbert M; ; Rookus M; Aalfs CM; Kluijt I; Boessenkool-Pape JL; Meijers-Heijboer HE; Oosterwijk JC; van Asperen CJ; Blok MJ; Nelen MR; van den Ouweland AM; Seynaeve C; van der Luijt RB; Devilee P; ; Easton DF; Peock S; Frost D; Platte R; Ellis SD; Fineberg E; Evans DG; Lalloo F; Eeles R; Jacobs C; Adlard J; Davidson R; Eccles D; Cole T; Cook J; Godwin A; Bove B; ; Stoppa-Lyonnet D; Caux-Moncoutier V; Belotti M; Tirapo C; Mazoyer S; Barjhoux L; Boutry-Kryza N; Pujol P; Coupier I; Peyrat JP; Vennin P; Muller D; Fricker JP; Venat-Bouvet L; Johannsson OT; Isaacs C; Schmutzler R; Wappenschmidt B; Meindl A; Arnold N; Varon-Mateeva R; Niederacher D; Sutter C; Deissler H; Preisler-Adams S; Simard J; Soucy P; Durocher F; Chenevix-Trench G; Beesley J; Chen X; ; Rebbeck T; Couch F; Wang X; Lindor N; Fredericksen Z; Pankratz VS; Peterlongo P; Bonanni B; Fortuzzi S; Peissel B; Szabo C; Mai PL; Loud JT; Lubinski J;
Br J Cancer; 2012 Jun; 106(12):2016-24. PubMed ID: 22669161
[TBL] [Abstract][Full Text] [Related]
5. Association between MTHFR gene polymorphism and the risk of ovarian cancer: a meta-analysis of the literature.
Pu D; Jiang SW; Wu J
Curr Pharm Des; 2014; 20(11):1632-8. PubMed ID: 24720627
[TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphism of methylenetetrahydrofolate reductase is associated with insulin resistance in Egyptian women with polycystic ovary syndrome.
Nsrallah AA; Abd-El Fatah AH; Ahmed HS
J Gene Med; 2019 Apr; 21(4):e3076. PubMed ID: 30743312
[TBL] [Abstract][Full Text] [Related]
7. The Frequency of the 677C>T and 1298A>C Polymorphisms in the Methylenetetrahydrofolate Reductase (MTHFR) Gene in the Population.
Nefic H; Mackic-Djurovic M; Eminovic I
Med Arch; 2018 Jun; 72(3):164-169. PubMed ID: 30061759
[TBL] [Abstract][Full Text] [Related]
8. Selected Aspects of Molecular Diagnostics of Constitutional Alterations in BRCA1 and BRCA2 Genes Associated with Increased Risk of Breast Cancer in the Polish Population.
Górski B
Hered Cancer Clin Pract; 2006 Aug; 4(3):142-52. PubMed ID: 20223018
[TBL] [Abstract][Full Text] [Related]
9. [Polymorphisms of methylenetetrahydrofolate reductase gene among women of childbearing age from Shiyan area].
Li J; Li Z; Zhang J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Aug; 35(4):572-576. PubMed ID: 30098259
[TBL] [Abstract][Full Text] [Related]
10. Association of MTHFR 677C>T Polymorphism with Susceptibility to Ovarian and Cervical Cancers: A Systematic Review and Meta-Analysis.
Karimi-Zarchi M; Moghimi M; Abbasi H; Hadadan A; Salimi E; Morovati-Sharifabad M; Akbarian-Bafghi MJ; Zare-Shehneh M; Mosavi-Jarrahi A; Neamatzadeh H
Asian Pac J Cancer Prev; 2019 Sep; 20(9):2569-2577. PubMed ID: 31554347
[TBL] [Abstract][Full Text] [Related]
11. Association of methylenetetrahydrofolate reductase (MTHFR 677C>T and 1298A>C) polymorphisms and haplotypes with silent brain infarction and homocysteine levels in a Korean population.
Han IB; Kim OJ; Ahn JY; Oh D; Hong SP; Huh R; Chung SS; Kim NK
Yonsei Med J; 2010 Mar; 51(2):253-60. PubMed ID: 20191019
[TBL] [Abstract][Full Text] [Related]
12. Association of methylenetetrahydrofolate reductase (MTHFR 677C>T) and thymidylate synthase (TSER and TS 1494del6) polymorphisms with premature ovarian failure in Korean women.
Rah H; Jeon YJ; Choi Y; Shim SH; Yoon TK; Choi DH; Cha SH; Kim NK
Menopause; 2012 Nov; 19(11):1260-6. PubMed ID: 22713864
[TBL] [Abstract][Full Text] [Related]
13. Association between MTHFR 677C/T polymorphism and psoriasis risk: a meta-analysis.
Qi JH; Qi JH; Shi N; Chen YJ; Nie G
Genet Mol Res; 2015 Apr; 14(2):3869-76. PubMed ID: 25966157
[TBL] [Abstract][Full Text] [Related]
14. Association between the methylenetetrahydrofolate reductase c.677C>T polymorphism and bone mineral density: an updated meta-analysis.
Li HZ; Wang W; Liu YL; He XF
Mol Genet Genomics; 2016 Feb; 291(1):169-80. PubMed ID: 26231982
[TBL] [Abstract][Full Text] [Related]
15. Methylenetetrahydrofolate reductase polymorphisms modify BRCA1-associated breast and ovarian cancer risks.
Jakubowska A; Gronwald J; Menkiszak J; Górski B; Huzarski T; Byrski T; Edler L; Lubiński J; Scott RJ; Hamann U
Breast Cancer Res Treat; 2007 Sep; 104(3):299-308. PubMed ID: 17063264
[TBL] [Abstract][Full Text] [Related]
16. The 677C>T mutation of the MTHFR gene increases the risk of venous thromboembolism in Koreans and a meta-analysis from Asian population.
Jang MJ; Jeon YJ; Choi WI; Choi YS; Kim SY; Chong SY; Oh D; Kim NK
Clin Appl Thromb Hemost; 2013 Jun; 19(3):309-14. PubMed ID: 22327825
[TBL] [Abstract][Full Text] [Related]
17. Role of methylenetetrahydrofolate reductase gene (MTHFR) 677C>T polymorphism in pediatric cerebrovascular disorders.
Alsayouf H; Zamel KM; Heyer GL; Khuhro AL; Kahwash SB; de los Reyes EC
J Child Neurol; 2011 Mar; 26(3):318-21. PubMed ID: 21270470
[TBL] [Abstract][Full Text] [Related]
18. Coexistence of the 677C>T and 1298A>C MTHFR polymorphisms and its significance in the population of Polish women.
Wolski H; Kocięcka M; Mrozikiewicz AE; Barlik M; Kurzawińska G
Ginekol Pol; 2015 Oct; 86(10):742-7. PubMed ID: 26677583
[TBL] [Abstract][Full Text] [Related]
19. The association between MTHFR 677C>T polymorphism and cervical cancer: evidence from a meta-analysis.
Mei Q; Zhou D; Gao J; Shen S; Wu J; Guo L; Liang Z
BMC Cancer; 2012 Oct; 12():467. PubMed ID: 23057736
[TBL] [Abstract][Full Text] [Related]
20. [Folate gene polymorphism and the risk of Down syndrome pregnancies in young Chinese women].
Liao YP; Bao MS; Liu CQ; Liu H; Zhang D
Yi Chuan; 2010 May; 32(5):461-6. PubMed ID: 20466634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
